Current perspectives on multidrug-resistant bacteria

Infectious Disease Clinics of North America

Volumn 10, Issue 4, 1996, Pages 939-957

  Segal Maurer, S ^a   Urban, C ^a   Rahal J J , Jr ^a  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; CARBAPENEM DERIVATIVE; CHLORAMPHENICOL; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; DOXYCYCLINE; ERYTHROMYCIN; GENTAMICIN; GLYCOPEPTIDE; IMIPENEM; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; QUINOLONE; RIFAMPICIN; STREPTOGRAMIN; SULBACTAM; TEICOPLANIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; DRUG EFFICACY; HIGH RISK PATIENT; HUMAN; INFECTION; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; REVIEW; STAPHYLOCOCCUS INFECTION;

EID: 0030464236     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70334-2     Document Type: Article

References (107)

1. American Thoracic Society Treatment of tuberculosis and tuberculosis infection in adults and children Am J Respir Crit Care Med 149 1994 1359
2. G.J. Annas Control of tuberculosis—the law and the public's health N Engl J Med 328 1993 585
3. P.C. Appelbaum Antimicrobial resistance in Streptococcus pneumoniae: An overview Clin Infect Dis 15 1992 77
4. M. Arthur P. Courvalin Genetics and mechanisms of glycopeptide resistance in enterococci Antimicrob Agents Chemother 37 1993 1563
5. Beezhold D, Slaughter S, Hayden MK, et al: Prevalence of skin colonization with vancomycin-resistant enterococci (VRE) in hospitalized patients with bacteremia [abstract 108]. In Abstracts of the 33rd Infectious Disease Society of America Annual Meeting, San Francisco, September 16–18, 1995, p 44.
6. A.B. Bloch G.M. Cauthen I.M. Onorato Nationwide survey of drug-resistant tuberculosis in the United States JAMA 271 1994 665
7. B.R. Bloom C.J.L. Murray Tuberculosis: Commentary on a reemergent killer Science 257 1992 1055
8. J.M. Boyce M.M. Jackson G. Pugliese Methicillin-resistant Staphylococcus aureus (MRSA): A briefing for acute care hospitals and nursing facilities Infect Control Hosp Epidemiol 15 1994 105
9. J.M. Boyce L.A. Mermel M.J. Zervos Controlling vancomycin-resistant enterococci Infect Control Hosp Epidemiol 16 1995 634
10. P.A. Bradford C. Urban A. Jaiswal SHV, a novel cefotaxime-hydrolyzing β-lactamase, identified in Escherichia coli isolates from hospitalized nursing home patients Antimicrob Agents Chemother 39 1995 899
11. R.F. Breiman J.C. Butler F.C. Tenover Emergence of drug-resistant pneumococcal infections in the United States JAMA 271 1994 1831
12. T.F. Brewer G.A. Colditz Bacille Calmette-Gue´rin vaccination for the prevention of tuberculosis in health care workers Clin Infect Dis 20 1995 136
13. D.R. Burwen S.N. Banerjee R.P. Gaynes Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States J Infect Dis 170 1994 1622
14. J.C. Butler R.F. Breiman H.B. Lipman Serotype distribution of Streptococcus pneumoniae infections among preschool children in the United States, 1978–1994: Implications for development of a conjugate vaccine J Infect Dis 171 1995 885
15. Centers for Disease Control Pneumococcal polysaccharide vaccine. Recommendations of the Immunization Practices Advisory Committee MMWR Morb Mortal Wkly Rep 38 1989 64
16. Centers for Disease Control Use of BCG vaccines in the control of tuberculosis MMWR Morb Mortal Wkly Rep 37 1988 663
17. Centers for Disease Control and Prevention Addressing emerging infectious disease threats: A prevention strategy for the United States MMWR Morb Mortal Wkly Rep 43 1994 1
18. Centers for Disease Control and Prevention Guidelines for preventing the transmission of Mycobacterium tuberculosis in health-care facilities, 1994 MMWR Morb Mortal Wkly Rep 43 RR-13 1994 1
19. Centers for Disease Control and Prevention Management of persons exposed to multidrug-resistant tuberculosis MMWR Morb Mortal Wkly Rep 41 1992 61
20. Centers for Disease Control and Prevention Nosocomial enterococci resistant to vancomycin—United States, 1989–1993 MMWR Morb Mortal Wkly Rep 42 1993 597
21. Centers for Disease Control and Prevention Purified protein derivative (PPD)—tuberculin anergy and HIV infection: Guidelines for anergy testing and management of anergic persons at risk of tuberculosis MMWR Morb Mortal Wkly Rep 40 RR-5 1992 27
22. Centers for Disease Control and Prevention Recommendations for preventing the spread of vancomycin resistance—recommendations from the Hospital Infection Control Practices Advisory Committee MMWR Morb Mortal Wkly Rep 44 RR-12 1995 1
23. Centers for Disease Control and Prevention Screening for tuberculosis and tuberculous infection in high-risk populations, and the use of preventive therapy for tuberculous infection in the United States: Recommendations of the Advisory Committee for Elimination of Tuberculosis MMWR Morb Mortal Wkly Rep 44 RR-11 1995 18
24. M.S. Cetron D.B. Jernigan R.F. Breiman Action plan for drug-resistant Streptococcus pneumoniae. Emerging Infectious Diseases 1 1995 64
25. I. Chopra J. Hodgson B. Metcalf New approaches to the control of infections caused by antibiotic-resistant bacteria JAMA 275 1996 401
26. J.W. Chow D.M. Kuritza M. Shales Clonal spread of vancomycin-resistant Enterococcus faecium between patients in three hospitals in two states J Clin Microbiol 31 1993 1609
27. G.A. Colditz T.F. Brewer C.S. Berkey Efficacy of BCG vaccine in the prevention of tuberculosis: Meta-analysis of the published literature JAMA 271 1994 698
28. de Lencastre H. SA´ Figueiredo A.M. C. Urban Multiple mechanisms of methicillin resistance and improved methods for detection in clinical isolates of Staphylococcus aureus. Antimicrob Agents Chemother 35 1991 632
29. S.K. DuBois M.S. Marriott S.G.B. Amyes TEM and SHV derived extended-spectrum β-lactamases: Relationship between selection, structure, and function J Antimicrob Chemother 35 1995 7
30. M.B. Edmond J.F. Ober D.L. Weinbaum Vancomycin-resistant Enterococcus faecium bacteremia: Risk factors for infection Clin Infect Dis 20 1995 1126
31. P.D. Ellner T.E. Kiehn R. Cammarata Rapid detection and identification of pathogenic mycobacteria by combining radiometric and nucleic acid probe methods J Clin Microbiol 26 1988 1349
32. R.J. Faville D.E. Zaske E.L. Kaplan Staphylococcus aureus endocarditis: Combined therapy with vancomycin and rifampin JAMA 240 1984 1963
33. T.R. Frieden P.I. Fujiwara R.M. Washko Tuberculosis in New York City—turning the tide N Engl J Med 333 1995 229
34. I.R. Friedland G.H. McCracken Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 331 1994 377
35. Garner J.S. Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals Infect Control Hosp Epidemiol 17 1996 53
36. K. Glanz H. Yang Communicating about risk of infectious diseases JAMA 275 1996 253
37. E. Go C. Urban J. Burns Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam Lancet 344 1994 1329
38. M. Goble M.D. Iseman L.A. Madsen Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin N Engl J Med 328 1993 527
39. D.A. Goldmann R.A. Weinstein R.P. Wenzel Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals—a challenge to hospital leadership JAMA 275 1996 234
40. M. Green J.H. Shlaes K. Barbadora Bacteremia due to vancomycin-dependent Enterococcus faecium. Clin Infect Dis 20 1995 712
41. R.W. Haley N.B. Cushion F.C. Tenover Eradication of endemic methicillin-resistant Staphylococcus aureus infections from a neonatal intensive care unit J Infect Dis 171 1995 614
42. L.C.F. Hibbert-Rogers J. Heritage D.M. Gascoyne-Binzi Molecular epidemiology of ceftazidime-resistant Enterobacteriaceae from patients on a paediatric oncology ward J Antimicrob Chemother 36 1995 65
43. R.E. Huebner M.F. Schein Bass J.B. Jr The tuberculin skin test Clin Infect Dis 17 1993 968
44. M.D. Iseman Treatment of multidrug-resistant tuberculosis N Engl J Med 329 1993 784
45. M.R. Jacobs Treatment and diagnosis of infections caused by drug-resistant Streptococcus pneumoniae. Clin Infect Dis 15 1992 119
46. G.A. Jacoby Genetics of extended-spectrum beta-lactamases Eur J Clin Microbiol Infect Dis 13 suppl 1 1994 2
47. G.A. Jacoby Prevalence and resistance mechanisms of common bacterial respiratory pathogens Clin Infect Dis 18 1994 951
48. D.B. Jernigan M.S. Cetron R.F. Breiman Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP)—a strategy from the DRSP Working Group JAMA 275 1996 206
49. J.A. Jernigan M.A. Clemence G.A. Stott Control of methicillin-resistant Staphylococcus aureus at a university hospital: One decade later Infect Control Hosp Epidemiol 16 1995 686
50. C.C. Johnson L. Slavoski M. Schwartz In vitro activity of RP 59500 (quinupristin/dalfopristin) against antibiotic-resistant strains of Streptococcus pneumoniae and enterococci Diagn Microbiol Infect Dis 21 1995 169
51. R.N. Jones H.S. Sader M.E. Erwin Emerging multiply-resistant enterococci among clinical isolates Diagn Microbiol Infect Dis 21 1995 85
52. G.P. Katsanis J. Spargo M.J. Ferraro Detection of Klebsiella pneumoniae and Escherichia coli strains producing extended spectrum β-lactamases J Clin Microbiol 32 1994 691
53. I. Klare H. Heier H. Claus Enterococcus faecium strains with vanA-mediated high-level glycopeptide resistance isolated from animal foodstuffs and fecal samples of humans in the community Microbial Drug Resistance 1 1995 265
54. D.L. Klein Pneumococcal conjugate vaccines: Review and update Microbial Drug Resistance 1 1995 49
55. K.P. Klugman I.R. Friedland Antibiotic-resistant pneumococci in pediatric disease Microbial Drug Resistance 1 1995 5
56. J.R. Knox Extended-spectrum and inhibitor resistant TEM-type β-lactamases: Mutations, specificity, and three-dimensional structure Antimicrob Agents Chemother 39 1995 2593
57. H.J. Koornhof A. Wasas K. Klugman Antimicrobial resistance in Streptococcus pneumoniae: A South African perspective Clin Infect Dis 15 1992 84
58. B. Kreiswirth J. Kornblum R.D. Arbeit Evidence for a clonal origin of methicillin resistance in Staphylococcus aureus. Science 259 1993 227
59. S. Lam C. Singer M. Tucci The challenge of vancomycin-resistant enterococci: A clinical and epidemiologic study Am J Infect Control 23 1995 170
60. Landman D, Quale J, Burney S, Effect of antibiotic therapy on infections with vancomycin-resistant enterococci (VRE) [abstract 151]. In Abstracts of the 32nd Infectious Disease Society of America Annual Meeting, Orlando, October 7–9, 1994, p 27-A
61. D.E. Low Quinupristin/Dalfopristin: Spectrum of activity, pharmacokinetics, and initial clinical experience Microbial Drug Resistance 1 1995 223
62. J.C. Lucet S. Cheuret D. Ducre Outbreak of multiply-resistant Enterobacteriaceae in an intensive care unit: Epidemiology and risk factors for acquisition Clin Infect Dis 22 1996 430
63. A. Mahmoudi M.D. Iseman Pitfalls in the care of patients with tuberculosis: Common errors and their association with the acquisition of drug resistance JAMA 270 1993 65
64. N. Markowitz E.L. Quinn L.D. Saravolatz Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection Ann Intern Med 117 1992 390
65. E.O. Mason L. Lamberth R. Lichenstein Distribution of Streptococcus pneumoniae resistant to penicillin in the USA and in-vitro susceptibility to selected oral antibiotics J Antimicrob Chemother 36 1995 1043
66. McGowan J.E. Jr Nosocomial tuberculosis: New progress in control and prevention Clin Infect Dis 21 1995 489
67. K.S. Meyer C. Urban J. Eagan Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins Ann Intern Med 119 1993 353
68. Montecalvo M.A. de Lancastre H. M. Carraher Natural history of colonization with vancomycin-resistant Enterococcus faecium. Infect Control Hosp Epidemiol 16 1995 680
69. F. Moreno C. Crisp J.H. Jorgensen Methicillin-resistant Staphylococcus aureus as a community organism Clin Infect Dis 21 1995 1308
70. Morris J.G. Jr D.K. Shay J.N. Hebden Enterococci resistant to multiple antimicrobial agents, including vancomycin Ann Intern Med 123 1995 250
71. S. Morris G.H. Bai P. Suffys Molecular mechanisms of multiple-drug resistance in clinical isolates of Mycobacterium tuberculosis. J Infect Dis 171 1995 954
72. T. Moulding A.K. Dutt L.B. Reichman Fixed-dose combinations of antituberculous medications to prevent drug resistance Ann Intern Med 122 1995 951
73. M.E. Mulligan K.A. Murray-Leisure B.S. Ribner Methicillin-resistant Staphylococcus aureus: A consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management Am J Med 94 1993 313
74. R.S. Munford T.V. Murphy Antimicrobial resistance in Streptococcus pneumoniae: Can immunization prevent its spread? J Invest Med 42 1994 613
75. A. Najjar B.E. Murray Failure to demonstrate a consistent in vitro bactericidal effect of trimethoprim-sulfamethoxazole against enterococci Antimicrob Agents Chemother 31 1987 808
76. National Committee for Clinical Laboratory Standards Performance standards for antimicrobial susceptibility testing Sixth Informational Supplement 15 14 1995 M100
77. J.M. Nava F. Bella J. Garau Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: A population-based study Clin Infect Dis 19 1994 884
78. W.C. Noble Z. Virani R. Cree Cotransfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC12201 to Staphylococcus aureus. FEMS Microbiol Lett 93 1992 195
79. A.H. Norris J.P. Reilly P.H. Edelstein Chloramphenicol for the treatment of vancomycin-resistant enterococcal infections Clin Infect Dis 20 1995 1137
80. G.A. Noskin I. Cooper L.R. Peterson Vancomycin-resistant Enterococcus faecium sepsis following persistent colonization Arch Intern Med 1555 1995 1445
81. G.A. Noskin V. Stosor I. Cooper Recovery of vancomycin-resistant enterococci on fingertips and environmental surfaces Infect Control Hosp Epidemiol 16 1995 577
82. S.M. Opal K.H. Mayer M.J. Steinberg Frequent acquisition of multiple strains of methicillin-resistant Staphylococcus aureus by health care workers in an endemic hospital environment Infect Control Hosp Epidemiol 11 1990 479
83. R. Pallares J. Lin˜ares M. Vadillo Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain N Engl J Med 333 1995 474
84. A.E. Panlilio D.H. Culver R.P. Gaynes Methicillin-resistant Staphylococcus aureus in US hospitals, 1975–1991 Infect Control Hosp Epidemiol 13 1992 582
85. J. Romero-Vivas M. Rubio C. Fernandez Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21 1995 1417
86. W.A. Rutala E.B.S. Katz R.J. Sherertz Environmental study of a methicillin-resistant Staphylococcus aureus epidemic in a burn unit J Clin Microbiol 18 1983 683
87. N. Salomon D.C. Perlman P. Friedmann Predictors and outcome of multidrug-resistant tuberculosis Clin Infect Dis 21 1995 1245
88. M.D. Sanford A.F. Widmer M.J. Bale Efficient detection and long-term persistence of the carriage of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 19 1994 1123
89. D.R. Schaberg D.H. Culver R.P. Gaynes Major trends in the microbial etiology of nosocomial infection Am J Med 91 suppl 3B 1991 72
90. S. Segal-Maurer G.E. Kalkut Environmental control of tuberculosis: Continuing controversy Clin Infect Dis 19 1994 299
91. K.A. Sepkowitz AIDS, tuberculosis, and the health care worker Clin Infect Dis 20 1995 232
92. I. Shalit S.A. Berger A. Gorea Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital Antimicrob Agents Chemother 33 1989 593
93. D.K. Shay S.A. Maloney M. Montecalvo Epidemiology and mortality risk of vancomycin-resistant enterococcal bloodstream infections J Infect Dis 172 1995 993
94. R. Shekar G. Chico S.N. Bass Household transmission of vancomycin-resistant Enterococcus faecium. Clin Infect Dis 21 1995 1511
95. J. Shuter E. Bellin Secondary prophylaxis for tuberculosis in patients infected with human immunodeficiency virus Clin Infect Dis 22 1996 398
96. P.M. Small R.W. Shafer P.C. Hopewell Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection N Engl J Med 328 1993 1137
97. R. Soeiro S. Segal-Maurer Tuberculosis: Nosocomial transmission and control of infection AIDS 8 suppl 1 1994 S239
98. S.J. Spindel L.J. Strausbaugh C. Jacobson Infections caused by Staphylococcus aureus in a Veterans' Affairs nursing home care unit: A 5-year experience Infect Control Hosp Epidemiol 16 1995 217
99. W.W. Stead Management of health care workers after inadvertent exposure to tuberculosis: A guide for the use of preventive therapy Ann Intern Med 122 1995 906
100. L.J. Strausbaugh K.B. Crossley B.A. Nurse Antimicrobial resistance in long-term-care facilities Infect Control Hosp Epidemiol 17 1996 129
101. J.M. Swenson N.C. Clark M.J. Ferraro Development of a standardized screening method for detection of vancomycin-resistant enterococci J Clin Microbiol 32 1994 1700
102. F.C. Tenover J.M. Hughes The challenges of emerging infectious disease, development and spread of multiply-resistant bacterial pathogens JAMA 275 1996 300
103. F.C. Tenover J.M. Swenson C.M. O'Hara Ability of commercial and reference antimicrobial susceptibility testing methods to detect vancomycin resistance in enterococci J Clin Microbiol 33 1995 1524
104. G.S. Turett E.E. Telzak L.V. Torian Improved outcomes for patients with multidrug-resistant tuberculosis Clin Infect Dis 21 1995 1238
105. C. Urban J.J. Rahal Acinetobacter baumannii: An emerging multiresistant nosocomial pathogen Alliance for the Prudent Use of Antibiotics (APUA) Newsletter 14 1995 1
106. R. Washko A. Dow K.J. Henning A citywide survey of vancomycin-resistant enterococcus—New York City, 1993 Clin Infect Dis 22 1996 136
107. S. Zaza H.M. Blumberg C. Beck-Sague` Nosocomial transmission of Mycobacterium tuberculosis: Role of health care workers in outbreak propagation J Infect Dis 172 1995 1542